Clin2
NCT06679062Possibly a fitRecruiting

Suvorexant for alcohol use disorder and PTSD

Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)Insomnia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
76 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 21 and 65 years old.
  • You need to have moderate to severe alcohol use disorder (AUD) and current PTSD symptoms that bother you.
  • You must be motivated to cut back or stop drinking, and be willing to work on your PTSD.
  • You should have trouble sleeping — a score of 7 or higher on the Insomnia Severity Index (ISI) questionnaire.
  • You cannot be taking other sleep medications, and you must agree to avoid them during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06655883Recruiting· Phase 3
Testing suvorexant for insomnia in people with opioid use disorder

This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.

Garden Grove, California
NCT07686731Not yet recruiting· Phase 4
Testing suvorexant for sleep and PTSD in veterans

This study tests if the sleep medication suvorexant can improve both sleep and PTSD symptoms in veterans. If you have PTSD and insomnia, and you are a veteran, this might be a treatment option for you.

San Francisco, California
NCT06788522Not yet recruiting· Phase 4
Testing a sleep medication to help with PTSD

This study tests if a medication that blocks a brain chemical called orexin can help people with PTSD sleep better and reduce fear. You must have chronic PTSD, trouble sleeping, and be a U.S. military veteran.

San Francisco, California
NCT06484075Recruiting· Phase 1/Phase 2
Suvorexant for alcohol use disorder: brain effects

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder by looking at its effects on brain activity. Participants will stay in the hospital for about a month, take suvorexant or a placebo, and have brain scans.

Bethesda, Maryland
NCT06580444Not yet recruiting· Phase 2
Study of brexanolone for PTSD and alcohol use in veterans

This trial tests if a drug called brexanolone can help veterans with both PTSD and alcohol use disorder. You will be asked about your drinking and PTSD symptoms, and may receive the drug in a lab setting.

NCT06335407Recruiting· Phase 1
Testing a new under-the-tongue med for alcohol use and trauma

This study tests a new sublingual (under-the-tongue) medication for people with alcohol use disorder who have also had a traumatic life event. It aims to see if the medication can help reduce drinking and related symptoms.

West Haven, Connecticut

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.